(DOWNLOAD) "Xechem, Inc. v. Bristol-Myers Squibb Company" by In the United States Court of Appeals for the Seventh Circuit # eBook PDF Kindle ePub Free
eBook details
- Title: Xechem, Inc. v. Bristol-Myers Squibb Company
- Author : In the United States Court of Appeals for the Seventh Circuit
- Release Date : January 23, 2004
- Genre: Law,Books,Professional & Technical,
- Pages : * pages
- Size : 68 KB
Description
The Hatch-Waxman amendments to the Food and Drug Act entitle pharmaceutical companies that first bring a drug to market to a five-year period of exclusivity, even if the drug is unpatented. 21 U.S.C. §355. Bristol-Myers Squibb was first to market with paclitaxel, a compound derived from the bark of the yew tree and useful in combating some cancers. Bristol-Myers calls its formulation Taxol, which has been a commercial success. The exclusivity period was due to expire in July 1997, and many other drug producers geared up to sell generic paclitaxel once the market opened.
 "Xechem, Inc. v. Bristol-Myers Squibb Company" by In the United States Court of Appeals for the Seventh Circuit # eBook PDF Kindle ePub Free){kind=link}